Titlebook: Cardiovascular Disease in AIDS; Giuseppe Barbaro,Franck Boccara Book 2009Latest edition Springer-Verlag Milan 2009 AIDS.Epidemiology.HIV.H

Daidzein

書目名稱Cardiovascular Disease in AIDS影響因子(影響力)




書目名稱Cardiovascular Disease in AIDS影響因子(影響力)學(xué)科排名




書目名稱Cardiovascular Disease in AIDS網(wǎng)絡(luò)公開度




書目名稱Cardiovascular Disease in AIDS網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cardiovascular Disease in AIDS被引頻次




書目名稱Cardiovascular Disease in AIDS被引頻次學(xué)科排名




書目名稱Cardiovascular Disease in AIDS年度引用




書目名稱Cardiovascular Disease in AIDS年度引用學(xué)科排名




書目名稱Cardiovascular Disease in AIDS讀者反饋




書目名稱Cardiovascular Disease in AIDS讀者反饋學(xué)科排名

consolidate

退潮

FADE

Cerebrovascular Disease in HIV-Infected Patients,fection cases. Their prevalence in clinical studies has been estimated to range from 40 to 70%, and a prospective study revealed that neurological findings were present in 90% of AIDS patients examined by a neurologist

尾隨

HIV-Associated Pulmonary Hypertension,in 200, much higher than the 1 in 200,000 found in the general population [3]. No differences have been found in the clinical, histologic, and hemodynamic features between patients with HIV-associated pulmonary hypertension and HIV-uninfected patients affected by primary pulmonary hypertension.

鞏固

Cardiological Emergencies in HIV-Infected Patients,, and the drugs used to treat HIV disease-i.e., zidovudine and protease inhibitors (PIs) in the era of highly active antiretroviral therapy (HAART) regimens-or to treat or prevent opportunistic infections and neoplasms (e.g., pentamidine, cotrimoxazole, interferon α) [2].

鞏固

Book 2009Latest editionon to cardiac illness in both children and adults. These studies show that subclinical echocardiographic abnormalities independently predict adverse outcomes and identify high-risk groups to be targeted for early intervention and therapy. The introduction of HAART has altered cardiovascular manifest

BOLT

背帶

Coronary Heart Disease in HIV-Infected Patients: Epidemiology,ovascular diseases and so could lead to cardiovascular over-mortality and over-morbidity. Cardiovascular diseases currently account for 7% of deaths among HIV-infected subjects in France, for 14% of non-HIV-related deaths [3], and about 16% of deaths among subjects with a good immunovirologic response to cART [4].

煞費苦心